The Key To Better Visual Inspection Practices
The Key To Better Visual Inspection Practices
InQuest Science has introduced a specialized software solution designed to bridge regulatory gaps in pharmaceutical manufacturing by offering a robust, compliant framework for visual inspection and defect management. Unlike generic Manufacturing Execution Systems, this tool is tailored specifically for the rigorous demands of parenteral and medical device industries, ensuring that companies can maintain precise control over product quality from raw materials to finished goods. By consolidating multi-sourced data into a unified electronic platform, it allows quality assurance teams to monitor the entire product lifecycle, identify inconsistencies early, and prevent potential batch recalls. The system addresses critical challenges in data integrity and regulatory compliance by automating the documentation of inspection processes and maintaining secure, blinded repositories of defect standards. It features specialized modules for training and qualification of both human inspectors and automated vision systems, ensuring adherence to strict FDA and pharmacopeial guidelines. By digitizing these workflows, the software significantly reduces the administrative burden and minimizes human error associated with manual data entry, thereby enhancing the reliability of inspection results and streamlining the audit trail for regulatory submissions. This development is highly relevant to open data discussions as it demonstrates the industry’s shift from isolated, paper-based records toward integrated, digital data ecosystems. While the system currently operates as a specialized vertical solution, its emphasis on comprehensive data consolidation, standardized defect libraries, and seamless integration with broader manufacturing systems highlights the growing necessity for interoperable data structures in regulated environments. It underscores how modern quality management relies not just on data collection, but on accessible, analyzable, and transparent digital records that facilitate continuous improvement and rigorous external scrutiny.
Source: pharmaceuticalonline.comPublished on 2025-10-28